IQVIA Holdings Q3FY26 Results: Earnings call scheduled for Oct 27

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • IQVIA Holdings Inc. will announce third-quarter 2026 financial results on October 27, 2026
  • Conference call and webcast scheduled for 9:00 am Eastern Time on the same day
  • Earnings release and financial information will be posted on the Investor Relations website
  • Webcast replay available approximately two hours after the live event concludes
powered bylight_fuzz_icon
52259275

*this image is generated using AI for illustrative purposes only.

IQVIA Holdings Inc. (NYSE: IQV) will announce its third-quarter 2026 financial results before the market opens on Tuesday, October 27, 2026. The global provider of clinical research services and healthcare intelligence has scheduled a management conference call for the same day.

The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website. Investors and analysts can access the presentation slides and webcast via the company’s investor portal.

Conference Call Details

The IQVIA management team will host a conference call and webcast at 9:00 am Eastern Time on October 27, 2026. Participants must register in advance through the Investor Relations website to receive a confirmation email containing dial-in details, a unique passcode, and a registrant ID.

A replay of the webcast will be available approximately two hours after the conclusion of the live event. The recording can be accessed via the IQVIA Investor Relations website.

Company Profile

IQVIA is a leading global provider of clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries. The company employs approximately 94,000 people in over 100 countries.

IQVIA’s solutions are powered by IQVIA Connected Intelligence™, leveraging high-quality health data, Healthcare-grade AI®, advanced analytics, and domain expertise. The company emphasizes responsible AI use with capabilities built on privacy, regulatory compliance, and patient safety standards.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might IQVIA's Q3 2026 earnings guidance influence the broader CRO sector's valuation multiples for the remainder of the fiscal year?

What specific metrics regarding Healthcare-grade AI® adoption will management highlight to demonstrate ROI on their Connected Intelligence™ platform?

Given the global workforce of 94,000, how are labor cost trends and wage inflation in key markets impacting IQVIA's operating margins?

like19
dislike

IQVIA prices $2 billion senior notes at 6.375% coupon due 2034

scanx
Reviewed by
Ritika DScanX News Team
Key Highlights
  • IQVIA priced $2 billion in senior notes due 2034 at a 6.375% annual interest rate
  • Proceeds will fully redeem Senior 5.000% Notes due 2026 and reduce revolving credit facility debt
  • Interest payments begin March 15, 2027, with maturity on March 15, 2034
  • Issuance expected on or about September 23, 2026, subject to closing conditions
powered bylight_fuzz_icon
50536823

*this image is generated using AI for illustrative purposes only.

IQVIA Holdings Inc. (NYSE: IQV) priced an offering of $2,000,000,000 in aggregate principal amount of senior notes due 2034. The transaction aims to refinance existing debt and strengthen the company’s balance sheet position.

The notes will bear interest at a rate of 6.375% per annum. Interest payments are scheduled semi-annually in arrears on March 15 and September 15 of each year, beginning on March 15, 2027. The issuance is expected to occur on or about September 23, 2026, subject to customary closing conditions.

Use of Proceeds

IQVIA stated that proceeds from the offering will be used for specific debt management activities:

  • Redeem in full the Issuer’s Senior 5.000% Notes due 2026.
  • Repay a portion of outstanding indebtedness under the Issuer’s revolving credit facility.
  • Pay fees and expenses related to the notes offering.

Offering Structure

The notes mature on March 15, 2034, unless earlier repurchased or redeemed according to their terms. The offering is being made only to persons reasonably believed to be qualified institutional buyers in the United States in reliance on Rule 144A under the Securities Act of 1933, as amended. Outside the United States, the notes are offered only to non-U.S. investors pursuant to Regulation S.

What the Numbers Show

The new issuance carries a coupon rate of 6.375%, which is higher than the 5.000% coupon on the 2026 notes being redeemed. This suggests a cost-of-capital increase for this tranche of debt, likely reflecting current market conditions or the extension of maturity from 2026 to 2034.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How will the increased interest expense from the 6.375% coupon impact IQVIA's net income and free cash flow over the next fiscal year?

What does the extension of debt maturity to 2034 signal about IQVIA's long-term capital allocation strategy and risk management approach?

Could this refinancing activity indicate that IQVIA is preparing for significant M&A activity or strategic investments in 2027-2028?

like17
dislike

More News on IQVIA Holdings Inc